Innovator IBD Breakout Opportunities ETF (BOUT)

Assets	$11.08M
Expense Ratio	0.85%
PE Ratio	30.60
Shares Out	300,000
Dividend (ttm)	$0.23
Dividend Yield	0.60%
Ex-Dividend Date	Dec 31, 2024
Payout Frequency	n/a
Payout Ratio	18.92%

Volume	1,227
Open	38.09
Previous Close	37.75
Day's Range	37.59 - 38.18
52-Week Low	31.08
52-Week High	42.41
Beta	1.06
Holdings	50
Inception Date	Sep 13, 2018

About BOUT

Fund Home Page

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is issued by Innovator.

• Asset Class: Equity
• Category: Mid-Cap Growth
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BOUT
• ETF Provider: Innovator
• Index Tracked: IBD Breakout Stocks Total Return

Top 10 Holdings

37.95% of assets

Name	Symbol	Weight
MasTec, Inc.	MTZ	3.95%
The Charles Schwab Corporation	SCHW	3.93%
ResMed Inc.	RMD	3.92%
First Bancorp	FBNC	3.91%
Microsoft Corporation	MSFT	3.84%
Kratos Defense & Security Solutions, Inc.	KTOS	3.80%
Royal Caribbean Cruises Ltd.	RCL	3.70%
Sportradar Group AG	SRAD	3.66%
Flutter Entertainment plc	FLUT	3.65%
Emerson Electric Co.	EMR	3.58%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 31, 2024	$0.22753	Jan 2, 2025
Jul 31, 2024	$0.0059	Aug 1, 2024
Dec 28, 2023	$0.43704	Jan 2, 2024
Dec 29, 2022	$0.39823	Jan 3, 2023
Dec 27, 2018	$0.0389	Jan 2, 2019

Performance

BOUT had a total return of 10.16% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.66%.